CDH1 and neoplasm: We observed that the expression levels of two mesenchymal markers such as N-cadherin and β-catenin were reduced, when tumor cells were treated with SLC-0111 and Cis-Pt combinatorial approach, conversely the epithelial marker E-cadherin was upregulated thus demonstrating a reversal of EMT (Fig. 6C and D).